Background-Spinal cord stimulation (SCS) may be a useful additional therapy for pain in patients with therapeutically refractory angina pectoris. But doubts remain about whether it also relieves ischaemia. Methods-Indices of ischaemia were studied with and without SCS in 10 patients with otherwise intractable angina and evidence of myocardial ischaemia on 48 h ambulatory electrocardiographic (ECG) recording. Primary end points assessed by 48 h ECG recordings were total ischaemic burden, number of ischaemic episodes, and duration of ischaemic episodes. In addition, symptoms were assessed by a diary of glyceryl trinitrate intake and anginal attacks. Results-During SCS the total ischaemic burden of the entire group was significantly reduced from a median of 27-9
Background-Spinal cord stimulation (SCS) may be a useful additional therapy for pain in patients with therapeutically refractory angina pectoris. But doubts remain about whether it also relieves ischaemia. Methods-Indices of ischaemia were studied with and without SCS in 10 patients with otherwise intractable angina and evidence of myocardial ischaemia on 48 h ambulatory electrocardiographic (ECG) recording. Primary end points assessed by 48 h ECG recordings were total ischaemic burden, number of ischaemic episodes, and duration of ischaemic episodes. In addition, symptoms were assessed by a diary of glyceryl trinitrate intake and anginal attacks. Results-During SCS the total ischaemic burden of the entire group was significantly reduced from a median of (1.9-278.2) before SCS to 0 (0-70 2) mm x min with SCS (p < 0.03). In This was accompanied by a significant improvement in symptoms with a reduction in daily glyceryl trinitrate intake from a median of 3*0 (0-10) before SCS to 0-3 (0-10) tablets per 48 h (p < 0.02) and a decrease in the frequency of anginal attacks from a median of 5*5 (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) in hospital. The ambulatory ECG recordings were obtained at home, and patients continued with their usual activities.
The primary end points were ischaemic indices assessed by 48 h ambulatory ECG recording (number and duration of ischaemic episodes and total ischaemia burden) and symptomatic ischaemia assessed by anginal attacks and glyceryl trinitrate intake scored in a 48 h diary during monitoring. Secondary end points were heart rates (minimum, average, and maximum), arrhythmias, and heart rate variability (HRV).
The electrodes were applied in the best position to show ST segment changes. We used the following leads: modified aVF, Vl, and V5. We used the same electrode positions for all recordings in individual patients. Three-channel amplitude-modulated Marquette recorders were used (series 8500). A fourth channel recorded a 32 Hz time signal, which was used in a phase-locked loop circuit (as well as a timer for the AD converter) to correct for tape speed irregularity.
The ECG was analysed on Marquette XP analyser (software version 5 8) and reviewed by an experienced analyst who was supervised by a cardiologist. ST changes caused by posture were eliminated. We corrected for preexisting ST segment deviation by computing the ST segment as a moving average over 9 5 h. Each episode of at least 0 1 mV of horizontal or downsloping ST depression at 60 ms after the J point, lasting for at least a minute, and separated from another episode by at least a minute of normal ST segment was regarded as an ischaemic episode.101 ' Because the characteristics of the default Marquette filter did not eliminate interference from stimulation artefacts on the surface ECG registrated by the ambulatory ECG recorder, we built in Krohn-Hite-tunable active filters (KH 3340) in low pass mode (for all three ECG channels separately) between the acquisition module and the ECG analyser.
In a pilot study in four patients we recorded ischaemic periods during 48 All ambulatory 48 h ECG recordings obtained in the 10 patients before SCS showed ST segment changes. During SCS treatment only four patients still had ST changes, and in three of these four the total ischaemic burden, the number of episodes of ischaemia, and their duration were reduced. The total ischaemic burden was reduced in the entire group from a median of (1.9-278 2) to 0 (0-70 2) mm x min (p < 0-03). The number of ischaemic episodes was reduced from a median of 3 (1-15) to 0 (0-9) with SCS (p < 0 04). The median (range) duration of ischaemia was 20-6 (1.7-155-4) minutes before SCS and 0 (0-48 3) minutes with SCS (p < 0-03). (TABLE 2) The frequency of anginal attacks dropped from a median of 5-5 (2-14) before SCS to 1-0 (0-10) 48 h after 6 weeks of SCS treatment (p < 0 03). In addition consumption of glyceryl trinitrate in 48 h decreased from a median of 3 0 (0-10) tablets per patient to 0 3 (0-10) (p < 0-02).
GTN INTAKE AND ANGINAL COMPIAINTS
HEART RATES AND ARRHYTHMIAS (TABLE 3) SCS did not significantly influence the average (mean (SD) 62-0 (20 0) before SCS and 59-6 (18-5) with SCS), minimal (40 5 (14-4) before SCS and 39 9 (13-4) with SCS) or maximal (106&9 (33 7) before SCS and 101-8 (31-7) with SCS) hgirt rate (beats/min) dur- (107) 37 (15) 103 (33) 10 (15) 93 (29) 23 (8) 5 (5) 21 (11) 12 (8) 8 (4) 30 (9) 14 ( (123) 35 (17) 115 (33) 11 (19) 91 (29) 25 (6) 5 (3) 25 (8) 14 (6) 9 (3) 31 (12) 14 (7) There were no statistically significant differences between the two groups. the correlation between ST segment shifts on ambulatory ECG recording and coronary artery disease.14 The relation between ST segment shifts on ambulatory ECG monitoring and regional myocardial ischaemia was validated by physiological radioisotopic studies in patients with known coronary artery disease.1516 Both the frequency and duration of ischaemia on ambulatory ECG recording correlated with physical activity and mental stress levels.17 Nonetheless there was also dayto-day variability in myocardial ischaemia.18 19 Does a reduction in ST depression, assessed during ambulatory ECG monitoring, alter the prognosis of patients with coronary artery disease? The answer seems to depend on the risk of an adverse cardiac event.202' We know of no other reports of prognosis in patients with intractable angina. Despite the improvement in exercise capacity, SCS did not seem to increase the occurrence of myocardial ischaemia and patients remained aware of the angina though the pain was reduced. Therefore, we do not expect SCS to worsen prognosis.
Changes in 48 h ECG monitoring produced by SCS during the unrestricted activities of normal life are unlikely to be due to chance alone. There is likely to be considerable variation in ambulatory ECGs between patients which is why in this study of SCS each patient acted as his or her own control.
AMBULATORY ST SEGMENT RECORDING DURING SPINAL CORD STIMULATION
To date ambulatory ECG monitoring is the best tool to evaluate myocardial ischaemia during daily life. During SCS, however, artefacts interfere with the ambulatory ECG recording. Fortunately, in our study the frequency content of the ST segment was below the cut off point of the KH low pass filter and the analysis of the ST segment was not hampered by the low pass filter.22 The significant improvement in the indices of ischaemia and symptoms that we showed in this study could be the result of an analgesic effect of SCS and an anti-ischaemic effect of SCS.
ANALGESIC EFFECT OF SCS
In 1967 Wall and Sweet reported that electrostimulation had an analgesic effect that was sustained after stimulation stopped.2 Though intermittent SCS may not have the same effects on myocardial ischaemia as does continuous SCS, both stimulation regimens had beneficial effects. [5] [6] [7] [8] [9] Transmission of the nociceptive cardiac signal to the CNS is mediated by slowly conducting A6 fibres and by even more slowly conducting C fibres. These afferent fibres run in parallel with the sympathetic (mainly epicardial) and parasympathetic (mainly endocardial) nerves from different regions in the heart to the dorsal column of the spinal cord (fig 1) . Sensory pain fibres of the heart project to cells at (T1-T5) level in the spinal cord. These cells are the origin of the spinothalamic tract. This classic pain pathway can relay pain stimuli to centres such as the thalamus and limbic system. These centres connect with the somatosensible cortex, the level at which an individual becomes aware of the nociceptive stimulus. Descending pathways from the limbic portion of the brain control the cardiovascular system to ensure the survival of the individual.
According to the so-called gate control model' stimulation of the dorsal spinal cord (SCS) can interrupt transmission of several types of (visceral) pain, such as angina. According to the hypothesis, transmission of pain from C fibres and A3 fibres to the substantia gelatinosa gate cells of the dorsal horn can be modulated. In addition, a higher central decoding mechanism can exert descending control on this gate setting. It has been known for a long time that stimulation of certain limbic structures alters coronary blood flow.23 These structures can modulate the sympathetic tone of the coronary arteries.
Because the transmission time of the impulses during SCS is too fast to explain persistence of the effect after stimulation has stopped, mechanisms other than the gate control theory must be involved. There is evidence of resetting within spinothalamic cells. In our study SCS was used intermittently three times a day for up to an hour each time.
We found that this protocol abolished ischaemia in six patients during the hours that SCS was not used. Ischaemia was reduced in three of the remaining four patients.
The potential for rebound ischaemia to develop, for instance after exercise, when SCS is temporarily withheld, must have been counterbalanced by the sustained anti-ischaemic influence, that we found in this study. Thus SCS is likely to be safe. In addition, the significant reduction in myocardial ischaemia by SCS in this study was accompanied by a significant decrease in angina symptoms (angina attacks and glyceryl trinitrate intake).
Mechanism of anti-ischaemic action It is not clear whether SCS reduces ischaemia by reducing myocardial oxygen consumption (as proposed by Mannheimer26) or by improving oxygen supply. The first mechanism is supported by a decrease in heart rate during SCS in an experimental study.27 This decrease in heart rate may counteract the increase in heart rate during ischaemic episodes.28 Increased parasympathetic activity or reduced sympathetic activity might explain the reduction in heart rate by SCS. We studied the possible alteration in the balance of the autonomic system caused by SCS by assessing HRV during the ambulatory ECG recording. We used Marquette HRV software version 2A for this analysis.
A decreased HRV was associated with the severity of ischaemic heart disease29 and with an increased risk in sudden death. 30 The patients in our study had moderately decreased to normal HRV, expressed as the SDNN of the normal intervals (table 3). In our study SCS did not influence HRV indices consistently. This may reflect the small sample size and method used. Moreover, we did not find a consistent effect of SCS on the minimum, average, or maximal heart rates.
Because all our patients had advanced intractable coronary artery disease and were on optimal medication, the reduction in myocardial ischaemia without any effect on the heart rate suggests an improved oxygen supply to the heart. This may be by redistribution of coronary blood flow.
In patients with severe peripheral vascular disease spinal cord stimulation enhanced the impaired blood flow in the affected limb, however, in patients with coronary artery disease positron emission tomography did not show redistribution of coronary blood flow. 
